Pigment Treatment
Zygomatices
Conception
Zygomatices presents as macules on the symmetrical distribution of zygomatic areas with black-to-gray, black-to-brown, gray-tobrown pigmentation.
Clinical feature
1. Mostly occurred in Female. Male-to-female
ratio is 1:13~18, onset age usually be 16 -40, some will be familial cases.
2. Presents as: black-to-gray, black-to-brown,
gray-to-brown;
3. Symmetrical distribution over zygomatic
areas, partly over eyelid and nose.
4. 1-5mm in diameter; round, oval or irregularly outlined, well-demarcated macules.
5. Number of macules: several or several
dozen, average 10-20;
6. Dose not elevated on or depressed in the
skin, has no symptom;
7. No relation with season and sunshine.
Histopathology
Melanocyte that has not migrated completely from the neural crest to the epidermis stays in the dermis during the embryonic stage.
Method of treatment
Because Zygomatices is a dermal melanocytic lesion, so Q-Switched ND:YAG laser is the first choice.
Recommended Equipment

YILLIYA-1064QCH
Dual wavelengths (1064nm & 532nm) are convenient to adjust by touching LCD. Multi-spot size (1-7mm) is ideal for a wide…
View details
Pmise-1064QCL
Dual wavelengths (1064nm & 532nm) are convenient to adjust by touching LCD. Multi-spot size (1-7mm) is ideal for a wide…
View details
Pmise-MV11
Patented technology of single lamp and dual rods doubles energy output (400mj). Shorter pulse width (6-8ns) than ordina…
View details